pubmed.ncbi.nlm.nih.gov

[Cystatin C and cardiovascular risk] - PubMed

[Article in Russian]

Review

[Cystatin C and cardiovascular risk]

[Article in Russian]

N Taglieri et al. Klin Lab Diagn. 2012 Oct.

No abstract available

Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus.
Garcia-Garcia P, Castejon R, Tutor-Ureta P, Silvestre RA, Mellor-Pita S, Jimenez-Ortiz C, Yebra-Bango M. Garcia-Garcia P, et al. Clin Rheumatol. 2017 Dec;36(12):2709-2717. doi: 10.1007/s10067-017-3837-9. Epub 2017 Sep 15. Clin Rheumatol. 2017. PMID: 28914371
Biomarkers of atherosclerosis: clinical applications.
Brown TM, Bittner V. Brown TM, et al. Curr Cardiol Rep. 2008 Nov;10(6):497-504. doi: 10.1007/s11886-008-0078-1. Curr Cardiol Rep. 2008. PMID: 18950561 Free PMC article. Review.
Association between serum cystatin C, monocytes and other inflammatory markers.
Evangelopoulos AA, Vallianou NG, Bountziouka V, Katsagoni C, Bathrellou E, Vogiatzakis ED, Bonou MS, Barbetseas J, Avgerinos PC, Panagiotakos DB. Evangelopoulos AA, et al. Intern Med J. 2012 May;42(5):517-22. doi: 10.1111/j.1445-5994.2011.02500.x. Intern Med J. 2012. PMID: 21470355
[Cistatin C as a novel marker of renal function impairement and cardiovascular risk].
Villeval'de SV, Gudgalis NI, Kobalava ZhD. Villeval'de SV, et al. Kardiologiia. 2010;50(6):78-82. Kardiologiia. 2010. PMID: 20659033 Review. Russian.